Medications for Opioidinduced Constipation

8 results

  • Lubiprostone (lubiprostone)

    (lubiprostone)
    Asclemed USA, Inc.
    Usage: Lubiprostone is indicated for the treatment of chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women aged 18 and older. Its effectiveness for certain opioid types remains unestablished.

  • Lubiprostone (lubiprostone)

    (Lubiprostone)
    Asclemed USA, Inc.
    Usage: Lubiprostone capsules are indicated for treating chronic idiopathic constipation in adults, opioid-induced constipation in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation in women aged 18 and older. Its effectiveness for opioid-induced constipation with certain opioids has not been established.

  • Lubiprostone (lubiprostone)

    (lubiprostone)
    Advanced Rx Pharmacy of Tennessee, LLC
    Usage: Lubiprostone is indicated for treating chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adults with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women aged 18 and older. Effectiveness in patients taking methadone for OIC is not established.

  • Lubiprostone (lubiprostone)

    (lubiprostone)
    Advanced Rx Pharmacy of Tennessee, LLC
    Usage: Lubiprostone is indicated for treating chronic idiopathic constipation (CIC) in adults, opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, and irritable bowel syndrome with constipation (IBS-C) in women over 18 years old. Effectiveness for OIC with certain opioids has not been established.

  • Movantik

    (naloxegol oxalate)
    RedHill Biopharma Ltd
    Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage increases.

  • Movantik (naloxegol oxalate)

    (naloxegol oxalate)
    Valinor Pharma, LLC
    Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with chronic pain from prior cancer or its treatment, provided they do not require frequent opioid dosage escalation.

  • Relistor

    (Methylnaltrexone bromide)
    Salix Pharmaceuticals, Inc.
    Usage: RELISTOR is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain or advanced illness requiring opioid escalation for palliative care, including those with chronic pain related to prior cancer or its treatment.

  • Symproic

    (naldemedine)
    BioDelivery Sciences International Inc
    Usage: SYMPROIC is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not need frequent opioid dosage increases.